Literature DB >> 3917550

Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy.

T O Carpenter, H L Levy, M E Holtrop, V E Shih, C S Anast.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917550     DOI: 10.1056/NEJM198501313120506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

2.  Lysinuric protein intolerance presenting as coma in a middle-aged man.

Authors:  M Gare; M Shalit; A Gutman
Journal:  West J Med       Date:  1996-10

3.  An unusual aminoacidopathy associated with mitochondrial encephalomyopathy.

Authors:  T L Perry; S Hansen; F A Booth; A M Penn; K Jones; L A Dilling
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Familial lysinuric protein intolerance presenting as coma in two adult siblings.

Authors:  P J Shaw; G Dale; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

5.  Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results.

Authors:  W H Waugh; C W Daeschner; B A Files; M E McConnell; S E Strandjord
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

6.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

7.  Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.

Authors:  E Svedström; K Parto; M Marttinen; P Virtama; O Simell
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

8.  Osteoporosis in lysinuric protein intolerance.

Authors:  K Parto; R Penttinen; I Paronen; L Pelliniemi; O Simell
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 9.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 10.  Drug treatment of inborn errors of metabolism: a systematic review.

Authors:  Majid Alfadhel; Khalid Al-Thihli; Hiba Moubayed; Wafaa Eyaid; Majed Al-Jeraisy
Journal:  Arch Dis Child       Date:  2013-03-26       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.